Cargando…

LAMA2 and LOXL4 are candidate FSGS genes

BACKGROUND: Focal and segmental glomerulosclerosis (FSGS) is a histologic pattern of injury that characterizes a wide spectrum of diseases. Many genetic causes have been identified in FSGS but even in families with comprehensive testing, a significant proportion remain unexplained. METHODS: In a fam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijayan, Poornima, Hack, Saidah, Yao, Tony, Qureshi, Mohammad Azfar, Paterson, Andrew D., John, Rohan, Davenport, Bernard, Lennon, Rachel, Pei, York, Barua, Moumita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474709/ https://www.ncbi.nlm.nih.gov/pubmed/34565340 http://dx.doi.org/10.1186/s12882-021-02524-6

Ejemplares similares

Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing
por: Brown, Elizabeth J., et al.
Publicado: (2014)

A heterozygous LAMA5 variant may contribute to slowly progressive, vinculin-enhanced familial FSGS and pulmonary defects
por: Kaimori, Jun-Ya, et al.
Publicado: (2022)

Therapeutic approach to FSGS in children
por: Gipson, Debbie S., et al.
Publicado: (2007)

FSGS: Diagnosis and Diagnostic Work-Up
por: Sprangers, Ben, et al.
Publicado: (2016)

The Impact of Histologic Variants on FSGS Outcomes
por: Meliambro, Kristin, et al.
Publicado: (2014)

FSGS Recurrence in Adults after Renal Transplantation
por: Rudnicki, Michael
Publicado: (2016)

Dalai Lama
Publicado: (2020)

Dalaï-Lama
Publicado: (2020)

Lamas in loops
por: Lai, Eric C.
Publicado: (2003)

Recurrence and Treatment after Renal Transplantation in Children with FSGS
por: Kang, Hee Gyung, et al.
Publicado: (2016)

Changing the Paradigm for the Treatment and Development of New Therapies for FSGS
por: Spino, Cathie, et al.
Publicado: (2016)

Increasing Options for First-Line Therapy in Primary FSGS?
por: Lafayette, Richard A.
Publicado: (2018)

Comparative proteomic analysis of children FSGS FFPE tissues
por: Ni, Jiajia, et al.
Publicado: (2022)

FSGS and COVID-19 in Non–African American Patients
por: Medina, Elba, et al.
Publicado: (2023)

Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)

Dalai Lama at CERN
Publicado: (1983)

Visit of Dalay Lama
Publicado: (1983)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

A Novel TRPC6 Mutation That Causes Childhood FSGS
por: Heeringa, Saskia F., et al.
Publicado: (2009)

Has the circulating permeability factor in primary FSGS been found?
por: Jefferson, J. Ashley, et al.
Publicado: (2013)

Compound effects of aging and experimental FSGS on glomerular epithelial cells
por: Schneider, Remington R.S, et al.
Publicado: (2017)

Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
por: Mitrofanova, Alla, et al.
Publicado: (2020)

Therapeutic trials in adult FSGS: lessons learned and the road forward
por: De Vriese, An S., et al.
Publicado: (2021)

Clinical and Pathological Heterogeneity in FSGS due to INF2 Mutations
por: Morales-Alvarez, Martha Catalina, et al.
Publicado: (2022)

Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis
por: Barua, Moumita, et al.
Publicado: (2013)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

Dalai Lama comes to CERN
Publicado: (1983)

A Conversation with the Grand Lama
Publicado: (1889)

Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor
por: Savin, Virginia J., et al.
Publicado: (2017)

Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese
por: Lee, Kelvin Y.C., et al.
Publicado: (2009)

LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

Effects of FSGS-associated mutations on the stability and function of myosin-1 in fission yeast
por: Bi, Jing, et al.
Publicado: (2015)

Genetic mutational testing of Chinese children with familial hematuria with biopsy-proven FSGS
por: Li, Yongzhen, et al.
Publicado: (2018)

The protective effect of Phellinus linteus decoction on podocyte injury in the kidney of FSGS rats
por: Wan, Feng, et al.
Publicado: (2019)

Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS
por: Bukosza, Eva Nora, et al.
Publicado: (2020)

Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression
por: Restrepo, Jaime M., et al.
Publicado: (2022)

Characterization of a Trpc6 Transgenic Mouse Associated with Early Onset FSGS
por: Canales, Cesar P., et al.
Publicado: (2014)

CUBN gene mutations may cause focal segmental glomerulosclerosis (FSGS) in children
por: Yang, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8trsdksvc5drt7v0cdal6015it